rs8065946

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_004035.7(ACOX1):​c.1320T>C​(p.Asp440Asp) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0143 in 1,614,130 control chromosomes in the GnomAD database, including 1,854 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.063 ( 931 hom., cov: 32)
Exomes 𝑓: 0.0092 ( 923 hom. )

Consequence

ACOX1
NM_004035.7 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: -0.0180

Publications

3 publications found
Variant links:
Genes affected
ACOX1 (HGNC:119): (acyl-CoA oxidase 1) The protein encoded by this gene is the first enzyme of the fatty acid beta-oxidation pathway, which catalyzes the desaturation of acyl-CoAs to 2-trans-enoyl-CoAs. It donates electrons directly to molecular oxygen, thereby producing hydrogen peroxide. Defects in this gene result in pseudoneonatal adrenoleukodystrophy, a disease that is characterized by accumulation of very long chain fatty acids. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Jul 2008]
ACOX1 Gene-Disease associations (from GenCC):
  • peroxisomal acyl-CoA oxidase deficiency
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), G2P, ClinGen, Ambry Genetics, Orphanet
  • Mitchell syndrome
    Inheritance: AD Classification: STRONG Submitted by: PanelApp Australia, ClinGen, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.53).
BP6
Variant 17-75949876-A-G is Benign according to our data. Variant chr17-75949876-A-G is described in ClinVar as Benign. ClinVar VariationId is 259220.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.018 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.206 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ACOX1NM_004035.7 linkc.1320T>C p.Asp440Asp synonymous_variant Exon 10 of 14 ENST00000293217.10 NP_004026.2 Q15067-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ACOX1ENST00000293217.10 linkc.1320T>C p.Asp440Asp synonymous_variant Exon 10 of 14 1 NM_004035.7 ENSP00000293217.4 Q15067-2

Frequencies

GnomAD3 genomes
AF:
0.0631
AC:
9605
AN:
152126
Hom.:
923
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.209
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0329
Gnomad ASJ
AF:
0.0395
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00414
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.0285
Gnomad NFE
AF:
0.00276
Gnomad OTH
AF:
0.0531
GnomAD2 exomes
AF:
0.0201
AC:
5060
AN:
251402
AF XY:
0.0162
show subpopulations
Gnomad AFR exome
AF:
0.216
Gnomad AMR exome
AF:
0.0178
Gnomad ASJ exome
AF:
0.0354
Gnomad EAS exome
AF:
0.0000544
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00319
Gnomad OTH exome
AF:
0.0150
GnomAD4 exome
AF:
0.00915
AC:
13380
AN:
1461886
Hom.:
923
Cov.:
32
AF XY:
0.00847
AC XY:
6160
AN XY:
727248
show subpopulations
African (AFR)
AF:
0.219
AC:
7339
AN:
33476
American (AMR)
AF:
0.0199
AC:
889
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.0336
AC:
877
AN:
26136
East Asian (EAS)
AF:
0.0000504
AC:
2
AN:
39700
South Asian (SAS)
AF:
0.00358
AC:
309
AN:
86258
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53420
Middle Eastern (MID)
AF:
0.0349
AC:
201
AN:
5766
European-Non Finnish (NFE)
AF:
0.00217
AC:
2411
AN:
1112010
Other (OTH)
AF:
0.0224
AC:
1352
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.478
Heterozygous variant carriers
0
744
1488
2233
2977
3721
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
270
540
810
1080
1350
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0634
AC:
9651
AN:
152244
Hom.:
931
Cov.:
32
AF XY:
0.0613
AC XY:
4563
AN XY:
74444
show subpopulations
African (AFR)
AF:
0.209
AC:
8686
AN:
41510
American (AMR)
AF:
0.0328
AC:
501
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.0395
AC:
137
AN:
3466
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5188
South Asian (SAS)
AF:
0.00414
AC:
20
AN:
4830
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10614
Middle Eastern (MID)
AF:
0.0272
AC:
8
AN:
294
European-Non Finnish (NFE)
AF:
0.00276
AC:
188
AN:
68024
Other (OTH)
AF:
0.0525
AC:
111
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
393
785
1178
1570
1963
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
90
180
270
360
450
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0276
Hom.:
487
Bravo
AF:
0.0720
Asia WGS
AF:
0.0180
AC:
65
AN:
3478
EpiCase
AF:
0.00567
EpiControl
AF:
0.00492

ClinVar

Significance: Benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Acyl-CoA oxidase deficiency Benign:3
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Sep 16, 2020
Natera, Inc.
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Dec 16, 2015
Mayo Clinic Laboratories, Mayo Clinic
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Sep 11, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.53
CADD
Benign
7.5
DANN
Benign
0.58
PhyloP100
-0.018
PromoterAI
0.010
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs8065946; hg19: chr17-73945957; API